WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Options
Query Language
Stem
Sort by:
List Length
1. (WO2016178240) A FREEZE DRIED PHARMACEUTICAL FORMULATION OF RIFABUTIN AND PROCESS FOR PREPARATION THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2016/178240 International Application No.: PCT/IN2015/000348
Publication Date: 10.11.2016 International Filing Date: 07.09.2015
IPC:
A61K 9/14 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
14
Particulate form, e.g. powders
Applicants: GUFIC BIOSCIENCES LIMITED[IN/IN]; N.H.No.8, Near Grid, Kabilpore 396 424 Navsari, Gujarat, IN
Inventors: PATEL, Mitesh Natavarlal; IN
DAVE, Mafatlal Tribhovandas; IN
CHOKSI, Pranavkumar Jayesh; IN
Agent: Gopakumar G. Nair; Patent and Trademark Attorney Gopakumar Nair Associates, 3rd Floor Shivmangal, Near Big Bazaar, Akurli Road Kandivali (East), Mumbai - 400 101, Maharashtra, IN
Priority Data:
1770/MUM/201504.05.2015IN
Title (EN) A FREEZE DRIED PHARMACEUTICAL FORMULATION OF RIFABUTIN AND PROCESS FOR PREPARATION THEREOF
(FR) FORMULATION PHARMACEUTIQUE LYOPHILISÉE DE RIFABUTINE ET PROCÉDÉ DE PRÉPARATION ASSOCIÉ
Abstract:
(EN) The present invention discloses a freeze dried pharmaceutical formulation of Rifabutin along with a suitable solubilizing agent and Bulking agent for parenteral administration which provides sufficient solubilization and stabilization of Rifabutin thus improving the shelf life and reduces the likelihood of precipitation during storage. The invention further discloses a process of preparation of said pharmaceutical formulation.
(FR) La présente invention concerne une formulation pharmaceutique lyophilisée de rifabutine conjointement à un agent solubilisant et un agent gonflant appropriés, destinée à être administrée par voie parentérale, et qui permet d'obtenir une solubilisation et une stabilisation suffisantes de la rifabutine, améliorant ainsi la durée de conservation et réduisant la probabilité de précipitation pendant le stockage. L'invention concerne également un procédé de préparation de ladite formulation pharmaceutique.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)